Magda Babina

Charité - Universitätsmedizin Berlin - Department of Dermatology and Allergy

Berlin

Germany

SCHOLARLY PAPERS

1

DOWNLOADS

37

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

An Allosteric Anti-Tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma

Number of pages: 64 Posted: 03 Mar 2019 Last Revised: 07 Oct 2019
Genentech, Inc. - San Francisco - Departments of Early Discovery Biochemistry, Genentech, Inc. - San Francisco - Department of Discovery Immunology, Genentech, Inc. - San Francisco - Biomarker Discovery OMNI, Genentech, Inc. - San Francisco - Biochemical and Cellular Pharmacology, Genentech, Inc. - San Francisco - Biomarker Discovery OMNI, Genentech, Inc. - San Francisco - Human Genetics, Genentech, Inc. - San Francisco - Bioinformatics, Genentech, Inc. - San Francisco - OMNI Biomarker Development, Genentech, Inc. - San Francisco - Biochemical and Cellular Pharmacology, Genentech, Inc. - San Francisco - Antibody Engineering, Genentech, Inc. - San Francisco - Antibody Engineering, University of California, San Francisco (UCSF), School of Medicine, Department of Medicine, Genentech, Inc. - San Francisco - Biochemical and Cellular Pharmacology, Genentech, Inc. - San Francisco - Departments of Early Discovery Biochemistry, Genentech, Inc. - San Francisco - Biomolecular Resources, Genentech, Inc. - San Francisco - Translational Immunology, Genentech, Inc. - San Francisco - Translational Immunology, Genentech, Inc. - San Francisco - Structural Biology, Genentech, Inc. - San Francisco - Human Genetics, Genentech, Inc. - San Francisco - Human Genetics, Genentech, Inc. - San Francisco - Biomolecular Resources, Genentech, Inc. - San Francisco - Protein Chemistry, Genentech, Inc. - San Francisco - Protein Chemistry, Genentech, Inc. - San Francisco - Protein Chemistry, Genentech, Inc. - San Francisco - Protein Chemistry, Genentech, Inc. - San Francisco - Preclinical and Translational Pharmacokinetics, Genentech, Inc. - San Francisco - Preclinical and Translational Pharmacokinetics, Genentech, Inc. - San Francisco - OMNI Biomarker Development, Virginia Commonwealth University (VCU), School of Medicine, Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Charité - Universitätsmedizin Berlin - Department of Dermatology and Allergy, University of California, San Francisco (UCSF) - Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Genentech, Inc. - San Francisco - Antibody Engineering, Genentech, Inc. - San Francisco - Antibody Engineering, Genentech, Inc. - San Francisco - Antibody Engineering, Genentech, Inc. - San Francisco - Safety Assessment, Genentech, Inc. - San Francisco - Safety Assessment, Genentech, Inc. - San Francisco - OMNI Biomarker Development, Genentech, Inc. - San Francisco - Translational Immunology, Genentech, Inc. - San Francisco - Departments of Early Discovery Biochemistry, Genentech, Inc. - San Francisco - Department of Discovery Immunology, Genentech, Inc. - San Francisco - OMNI Biomarker Development, Genentech, Inc. - San Francisco - Bioinformatics, Genentech, Inc. - San Francisco - Structural Biology, Genentech, Inc. - San Francisco - Department of Discovery Immunology, Genentech, Inc. - San Francisco - Departments of Early Discovery Biochemistry and Genentech, Inc. - San Francisco - Department of Discovery Immunology
Downloads 37 (793,892)

Abstract:

Loading...